Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technomark Life Sciences
Durham, North Carolina, United Statestechnomarkls.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Technomark Life Sciences co-invests in, and co-develops, preclinical to Phase 3 drug candidates and med-tech products via a hands-on, risk-sharing model with biotech partners. Their most advanced asset, ensereptide, is in Phase 3 for surgical adhesion (originated by Promore Pharma).
- Therapeutic areas
- OncologyOther
- Modalities
- Synthetic peptide
- Industry
- Investors
02
Partnerships
Promore Pharma ABPique Therapeutics, Inc.
Beyond the preview
Go deeper on Technomark Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Technomark Life Sciences.